{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:13:21Z","timestamp":1779290001792,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1982,12,1]],"date-time":"1982-12-01T00:00:00Z","timestamp":407548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1982,12,1]],"date-time":"1982-12-01T00:00:00Z","timestamp":407548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1982,12]]},"DOI":"10.1136\/ard.41.6.557","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"557-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases."],"prefix":"10.1016","volume":"41","author":[{"given":"P","family":"Hollingworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"de Vere Tyndall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Platts-Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M","family":"Gumpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M","family":"Denman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-73-6-881","article-title":"Combination chemotherapy in the treatment of advanced Hodgkin's disease","volume":"73","author":"T, De Vita V.; A, Serpick A.; P, Carbone P.","year":"1970","unstructured":"De Vita V T, Serpick A A, Carbone P P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73: 881-95.","journal-title":"Ann Intern Med"},{"key":"ref_2","first-page":"2272","article-title":"Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies","volume":"29","author":"S, Henderson E.; J, Samaha R.","year":"1969","unstructured":"Henderson E S, Samaha R J. Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies. Cancer Res 1969; 29: 2272-80.","journal-title":"Cancer Res"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00007890-197910000-00006","article-title":"Antithymocyte globulin (ATGAM) in renal allograft recipients","volume":"28","author":"J, Wechter W.; A, Brodie J.; M, Morrell R.; M, Rafi; R, Schultz J.","year":"1979","unstructured":"Wechter W J, Brodie J A, Morrell R M, Rafi M, Schultz J R. Antithymocyte globulin (ATGAM) in renal allograft recipients. Transplantation 1979; 28: 294-302.","journal-title":"Transplantation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan, A.; B, Peter J.","year":"1975","unstructured":"Bohan A, Peter J B. Polymyositis and dermatomyositis. N EnglJ Med 1975; 292: 344-7, 403-7.","journal-title":"N EnglJ Med"},{"key":"ref_5","first-page":"643","article-title":"Preliminary criteria for the classification of systemic lupus erythematosus","volume":"21","author":"S, Cohen A.; E, Reynolds W.; C, Franklin E.","year":"1971","unstructured":"Cohen A S, Reynolds W E, Franklin E C, et al. Preliminary criteria for the classification of systemic lupus erythematosus. BuU Rheum Dis 1971; 21: 643.","journal-title":"BuU Rheum Dis"},{"key":"ref_6","first-page":"146","article-title":"Clinical features, prognosis and response to treatment","volume-title":"polyarteritis. Mayo Clin Proc 1980; 55","author":"D, Cohen R.; L, Conn D.; M, Ilstrup D.","unstructured":"Cohen R D, Conn D L, Ilstrup D M. Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 1980; 55: 146-55."},{"key":"ref_7","first-page":"1399","article-title":"Treatment of polyarteritis nodosa with cortisone: results after three years: report to the Medical Research Council by the Collagen Diseases and","volume":"i:","year":"1960","unstructured":"Treatment of polyarteritis nodosa with cortisone: results after three years: report to the Medical Research Council by the Collagen Diseases and Hypersensitivity Panel. BrMed J 1960; i: 1399-400.","journal-title":"Hypersensitivity Panel. BrMed J"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM197908023010503","article-title":"Cyclophosphamide therapy of severe systemic necrotising vasculitis","volume":"301","author":"S, Fauci A.; P, Katz; F, Haynes; M, Wolff S.","year":"1979","unstructured":"Fauci A S, Katz P, Haynes F, Wolff S M. Cyclophosphamide therapy of severe systemic necrotising vasculitis. N Engl J Med 1979; 301: 235-8.","journal-title":"N Engl J Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archpedi.1971.02100160094014","article-title":"Periarteritis nodosa: a remission achieved with combined prednisolone and azathioprine therapy","volume":"121","author":"Melam, H.; Patterson, R.","year":"1971","unstructured":"Melam H, Patterson R. Periarteritis nodosa: a remission achieved with combined prednisolone and azathioprine therapy. Am J Dis Child 1971; 121: 424-7.","journal-title":"Am J Dis Child"},{"key":"ref_10","first-page":"225","article-title":"A computerassisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan, A.; B, Peter J.; L, Bowman R.; M, Pearson C.","year":"1977","unstructured":"Bohan A, Peter J B, Bowman R L, Pearson C M. A computerassisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltmore) 1977; 56: 225-86.","journal-title":"Medicine (Baltmore)"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine forpolymyositis","volume":"24","author":"BunchTW","year":"1981","unstructured":"BunchTW. Prednisone and azathioprine forpolymyositis.Arthritis Rheum 1981; 24: 45-8.","journal-title":"Arthritis Rheum"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.23.1.55","article-title":"Treatment of polymyositis with cytotoxic drugs","volume":"23","author":"C, Haas D.","year":"1973","unstructured":"Haas D C. Treatment of polymyositis with cytotoxic drugs. Neurology (Minneap) 1973; 23: 55-62.","journal-title":"Neurology (Minneap)"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-81-2-182","article-title":"Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy","volume":"81","author":"Metzger, A.; Bohan, A.; Goldberg, L.","year":"1974","unstructured":"Metzger A, Bohan A, Goldberg L, et al. Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med 1974; 81: 182-9.","journal-title":"Ann Intern Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.39.5.500","article-title":"Muscle biopsy in polymyositis and dermatomyositis: a clinicopathological study","volume":"39","author":"A, Schwarz H.; G, Slavin; P, Ward; M, Ansell B.","year":"1980","unstructured":"Schwarz H A, Slavin G, Ward P, Ansell B M. Muscle biopsy in polymyositis and dermatomyositis: a clinicopathological study. Ann Rheum Dis 1980; 39: 500-7.","journal-title":"Ann Rheum Dis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.1780140511","article-title":"Azathioprine in the treatment of systemic lupus erythematosus","volume":"14","author":"Sztejnbok, M.; Stewart, A.; Diamond, H.; Kaplan, D.","year":"1971","unstructured":"Sztejnbok M, Stewart A, Diamond H, Kaplan D. Azathioprine in the treatment of systemic lupus erythematosus. Arthritis Rheum 1971; 14: 639-45.","journal-title":"Arthritis Rheum"},{"key":"ref_16","first-page":"592","article-title":"Azathioprine plus prednisone compared with prednisone alone in the treatment","volume":"83","author":"S. L. E.","year":"1975","unstructured":"Hahn B, Kantor 0, Osterland K. Azathioprine plus prednisone compared with prednisone alone in the treatment of S.L.E. Ann Intern Med 1975; 83: 592-605.","journal-title":"Ann Intern Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/art.1780170511","article-title":"Further observations in the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine","volume":"17","author":"V, Donadio J.; E, Holley K.; D, Wagoner R.; H, Fergusen R.; C, McDuffie F.","year":"1974","unstructured":"Donadio J V, Holley K E, Wagoner R D, Fergusen R H, McDuffie F C. Further observations in the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthritis Rheum 1974; 17: 573-81.","journal-title":"Arthritis Rheum"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-75-2-165","article-title":"Cyclophosphamide in lupus nephritis. A controlled trial","volume":"75","author":"D, Steinberg A.; B, Kaltreider H.; J, Staples P.; J, Goetzel E.; N, Talal; L, Decker J.","year":"1971","unstructured":"Steinberg A D, Kaltreider H B, Staples P J, Goetzel E J, Talal N, Decker J L. Cyclophosphamide in lupus nephritis. A controlled trial. Ann Intern Med 1971; 75: 165-71.","journal-title":"Ann Intern Med"},{"key":"ref_19","first-page":"484","article-title":"Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and","volume-title":"cyclophosphamide. Mayo Clin Proc 1976; 51","author":"V, Jr, Donadio J.; E, Holley K.; H, Ferguson R.; M, Ilstrup D.","unstructured":"Donadio J V Jr, Holley K E, Ferguson R H, Ilstrup D M. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc 1976; 51: 484-94."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/1529-0131(197607\/08)19:4<693::AID-ART1780190406>3.0.CO;2-2","article-title":"Prednisone and azathioprine compared to prednisone and low dose azathioprine and cyclophosphamide in the treatment of lupus nephritis","volume":"19","author":"Ginzler, E.; Diamond, H.; Guttadauria, M.; Kaplan, D.","year":"1976","unstructured":"Ginzler E, Diamond H, Guttadauria M, Kaplan D. Prednisone and azathioprine compared to prednisone and low dose azathioprine and cyclophosphamide in the treatment of lupus nephritis. Arthritis Rheum 1976; 19: 693-9.","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724136357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724136357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.41.6.557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:21:54Z","timestamp":1737526914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724136357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1982,12]]}},"alternative-id":["S0003496724136357"],"URL":"https:\/\/doi.org\/10.1136\/ard.41.6.557","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1982,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.41.6.557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1982 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}